Your Input: | |||||
Mapk11 | Mitogen-activated protein kinase. (355 aa) | ||||
Cdkn2d | Cyclin-dependent kinase 4 inhibitor D. (166 aa) | ||||
Suz12 | Polycomb protein SUZ12. (726 aa) | ||||
Kxd1 | ubiquitin-60S ribosomal protein L40. (232 aa) | ||||
Cdkn2a | Cyclin-dependent kinase inhibitor 2A. (157 aa) | ||||
Map2k7 | Dual specificity mitogen-activated protein kinase kinase 7 isoform X1. (520 aa) | ||||
Nrk | Nik-related protein kinase. (357 aa) | ||||
Txn1 | Thioredoxin; Belongs to the thioredoxin family. (105 aa) | ||||
LOC106023108 | Polyhomeotic-like protein 1. (41 aa) | ||||
Mapkapk3 | MAP kinase-activated protein kinase 3; Belongs to the protein kinase superfamily. (384 aa) | ||||
Mapkapk2 | MAP kinase-activated protein kinase 2; Belongs to the protein kinase superfamily. (386 aa) | ||||
Map3k15 | Mitogen-activated protein kinase kinase kinase 15. (1197 aa) | ||||
Mapk8 | Mitogen-activated protein kinase. (427 aa) | ||||
Jun | Transcription factor AP-1; Belongs to the bZIP family. (338 aa) | ||||
ENSMAUP00000005256 | annotation not available (73 aa) | ||||
Nptx1 | Neuronal pentraxin-1. (432 aa) | ||||
Txndc8 | Thioredoxin domain-containing protein 8. (152 aa) | ||||
Rps27a | ubiquitin-40S ribosomal protein S27a. (156 aa) | ||||
Ezh1 | Histone-lysine N-methyltransferase EZH1. (747 aa) | ||||
ENSMAUP00000005944 | annotation not available (404 aa) | ||||
LOC101823019 | Ubiquitin-like. (114 aa) | ||||
Ezh2 | Histone-lysine N-methyltransferase EZH2 isoform X2. (745 aa) | ||||
ENSMAUP00000007258 | annotation not available (117 aa) | ||||
Rbbp7 | Histone-binding protein RBBP7. (425 aa) | ||||
ENSMAUP00000007717 | annotation not available (351 aa) | ||||
LOC101842493 | Protein Mdm4; Inhibits p53- and p73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Belongs to the MDM2/MDM4 family. (236 aa) | ||||
Map4k4 | Mitogen-activated protein kinase kinase kinase kinase 4 isoform X13. (1289 aa) | ||||
Cdk4 | Cyclin-dependent kinase 4; Belongs to the protein kinase superfamily. (303 aa) | ||||
Phc2 | Polyhomeotic-like protein 2 isoform X1. (323 aa) | ||||
Mapk3 | Mitogen-activated protein kinase. (380 aa) | ||||
ENSMAUP00000012323 | annotation not available (353 aa) | ||||
Cbx2 | Chromobox protein homolog 2. (518 aa) | ||||
Kdm6b | Lysine-specific demethylase 6B isoform X4. (1652 aa) | ||||
Mov10 | Putative helicase MOV-10 isoform X1. (1077 aa) | ||||
Rbbp4 | RB binding protein 4, chromatin remodeling factor. (391 aa) | ||||
Mapkapk5 | MAP kinase-activated protein kinase 5. (392 aa) | ||||
Fosl2 | Fos-related antigen 2. (324 aa) | ||||
Mapk14 | Mitogen-activated protein kinase. (360 aa) | ||||
Tnrc6b | Trinucleotide repeat-containing gene 6B protein. (1805 aa) | ||||
Nme8 | Thioredoxin domain-containing protein 3 isoform X1. (586 aa) | ||||
Mapk10 | Mitogen-activated protein kinase 10. (252 aa) | ||||
Mapk1 | Mitogen-activated protein kinase; Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. MAP kinase subfamily. (358 aa) | ||||
Mapk9 | Mitogen-activated protein kinase. (423 aa) | ||||
Map3k6 | Mitogen-activated protein kinase kinase kinase 6 isoform X1. (1289 aa) | ||||
LOC101839356 | Histone H2B; Belongs to the histone H2B family. (126 aa) | ||||
Nptx2 | Neuronal pentraxin-2. (432 aa) | ||||
ENSMAUP00000019419 | annotation not available (406 aa) | ||||
ENSMAUP00000019431 | annotation not available (150 aa) | ||||
ENSMAUP00000019554 | annotation not available (231 aa) | ||||
Map3k5 | Mitogen-activated protein kinase kinase kinase 5 isoform X2. (1381 aa) | ||||
Eed | Polycomb protein EED. (361 aa) | ||||
Fos | Proto-oncogene c-Fos; Nuclear phosphoprotein which forms a tight but non-covalently linked complex with the JUN/AP-1 transcription factor. On TGF-beta activation, forms a multimeric SMAD3/SMAD4/JUN/FOS complex, at the AP1/SMAD-binding site to regulate TGF-beta-mediated signaling. Has a critical function in regulating the development of cells destined to form and maintain the skeleton. It is thought to have an important role in signal transduction, cell proliferation and differentiation (By similarity). In growing cells, activates phospholipid synthesis, possibly by activating CDS1 and [...] (381 aa) | ||||
Cdkn2c | Cyclin-dependent kinase 4 inhibitor C. (168 aa) | ||||
Mink1 | Misshapen-like kinase 1 isoform X7. (1319 aa) | ||||
Cdkn2b | Cyclin-dependent kinase 4 inhibitor B isoform X1. (130 aa) | ||||
ENSMAUP00000022314 | annotation not available (101 aa) | ||||
Map2k3 | Dual specificity mitogen-activated protein kinase kinase 3; Belongs to the protein kinase superfamily. (347 aa) | ||||
Tnik | TRAF2 and NCK-interacting protein kinase. (538 aa) | ||||
Map2k6 | Dual specificity mitogen-activated protein kinase kinase 6 isoform X1; Belongs to the protein kinase superfamily. (334 aa) | ||||
Cdk6 | Cyclin-dependent kinase 6. (203 aa) | ||||
Cbx6 | Neuronal pentraxin receptor. (471 aa) | ||||
Map2k4 | Dual specificity mitogen-activated protein kinase kinase 4 isoform X2; Belongs to the protein kinase superfamily. (131 aa) | ||||
MDM2 | E3 ubiquitin-protein ligase Mdm2; E3 ubiquitin-protein ligase that mediates ubiquitination of p53/TP53, leading to its degradation by the proteasome. Inhibits p53/TP53- and p73/TP73-mediated cell cycle arrest and apoptosis by binding its transcriptional activation domain. Also acts as a ubiquitin ligase E3 toward itself and ARRB1. Permits the nuclear export of p53/TP53. Promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma RB1 protein. Inhibits DAXX-mediated apoptosis by inducing its ubiquitination and degradation. Component of the TRIM28/KAP1-MDM2-p53/TP53 [...] (270 aa) | ||||
Tp53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its intera [...] (395 aa) |